Search research articles
Contact Us
Filters
Showing results (91-100 of 107) with videos related to
Page
of 11
Sort By:
Gynecologic Oncology
|
December 21, 2010
A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q)
Thomas J Herzog, Michael W Sill, Joan L Walker, et al.
ACS Infectious Diseases
|
October 12, 2023
Biochemical and Cellular Characterization of the Function of Fluorophosphonate-Binding Hydrolase H (FphH) in <i>Staphylococcus aureus</i> Support a Role in Bacterial Stress Response
Matthias Fellner, Annabel Walsh, Stephen Dela Ahator, et al.
ACS Infectious Diseases
|
October 15, 2016
Design of Selective Substrates and Activity-Based Probes for Hydrolase Important for Pathogenesis 1 (HIP1) from Mycobacterium tuberculosis
Christian S Lentz, Alvaro A Ordonez, Paulina Kasperkiewicz, et al.
Antimicrobial Agents and Chemotherapy
|
October 15, 2014
In vitro activity of wALADin benzimidazoles against different life cycle stages of Plasmodium parasites
Christian S Lentz, Julia M Sattler, Martina Fendler, et al.
The Journal of Urology
|
May 20, 2026
Urine tumor DNA testing identifies recurrence and monitors therapy response in patients with high-risk non-muscle-invasive bladder cancer receiving intravesical bacillus Calmette-Guérin
Henning Bahlburg, Moritz Maas, Alberto Contreras-Sanz, et al.
Journal of Clinical Medicine
|
October 14, 2022
Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of Intervention
Vincent T Bicocca, Kevin G Phillips, Daniel S Fischer, et al.
Molecular Oncology
|
September 27, 2023
Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy
Goran Rac, Hiten D Patel, Christopher James, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 5, 2010
Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry
Cyril William Helm, Scott D Richard, Jianmin Pan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 26, 2014
Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study
Jonathan S Berek, Robert P Edwards, Lynn P Parker, et al.
EMBO Molecular Medicine
|
April 1, 2025
Saccharin disrupts bacterial cell envelope stability and interferes with DNA replication dynamics
Rubén de Dios, Kavita Gadar, Chris R Proctor, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 107) with videos related to
Sort By:
Page
of 11
Gynecologic Oncology
|
December 21, 2010
A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q)
Thomas J Herzog, Michael W Sill, Joan L Walker, et al.
ACS Infectious Diseases
|
October 12, 2023
Biochemical and Cellular Characterization of the Function of Fluorophosphonate-Binding Hydrolase H (FphH) in <i>Staphylococcus aureus</i> Support a Role in Bacterial Stress Response
Matthias Fellner, Annabel Walsh, Stephen Dela Ahator, et al.
ACS Infectious Diseases
|
October 15, 2016
Design of Selective Substrates and Activity-Based Probes for Hydrolase Important for Pathogenesis 1 (HIP1) from Mycobacterium tuberculosis
Christian S Lentz, Alvaro A Ordonez, Paulina Kasperkiewicz, et al.
Antimicrobial Agents and Chemotherapy
|
October 15, 2014
In vitro activity of wALADin benzimidazoles against different life cycle stages of Plasmodium parasites
Christian S Lentz, Julia M Sattler, Martina Fendler, et al.
The Journal of Urology
|
May 20, 2026
Urine tumor DNA testing identifies recurrence and monitors therapy response in patients with high-risk non-muscle-invasive bladder cancer receiving intravesical bacillus Calmette-Guérin
Henning Bahlburg, Moritz Maas, Alberto Contreras-Sanz, et al.
Journal of Clinical Medicine
|
October 14, 2022
Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of Intervention
Vincent T Bicocca, Kevin G Phillips, Daniel S Fischer, et al.
Molecular Oncology
|
September 27, 2023
Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy
Goran Rac, Hiten D Patel, Christopher James, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 5, 2010
Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry
Cyril William Helm, Scott D Richard, Jianmin Pan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 26, 2014
Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study
Jonathan S Berek, Robert P Edwards, Lynn P Parker, et al.
EMBO Molecular Medicine
|
April 1, 2025
Saccharin disrupts bacterial cell envelope stability and interferes with DNA replication dynamics
Rubén de Dios, Kavita Gadar, Chris R Proctor, et al.
Page
of 11